% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • android_stocks android_stocks Mar 1, 2012 3:45 PM Flag

    Another statictically shocking data

    No panel means either very good news or very bad news.

    But I assert that FDA approval is a "sell on the news event", because the bigger question is life of patent.

    If AMRN is unable get its patent extended, it will expire in 2 years. So AMRN will end up doing all the work only to have generics come in.

3.225-0.025(-0.77%)10:14 AMEDT